BILL ANALYSIS Ó SCR 65 Page 1 Date of Hearing: August 30, 2013 ASSEMBLY COMMITTEE ON RULES Richard S. Gordon, Chair SCR 65 (Fuller/Vidak) - As Introduced: August 12, 2013 SENATE VOTE : 37-0 SUBJECT : Adrenoleukodystrophy Awareness Month. SUMMARY : Memorializes the month of November 2013 as Adrenoleukodystrophy Awareness Month. Specifically, this resolution makes the following legislative findings: 1)X-linked adrenoleudodystrophy (X-ALD) is one of a group of genetic disorders called the leukodystrohpies that cause damage to the myelin sheath. An insulating membrane that surrounds the nerve cells in the brain; and, X-ALD affects an estimated one in 20,000 boys, which is roughly 13,600 people in the United States, including boys like Jeremy Hill Jr. of Bakersfield. 2)Women have two X chromosomes and are the carriers of the disease, but men are most severely affected because men only have one X chromosome and lack the protection provided by the extra X chromosome. 3)Nearly all patients with X-ALD suffer from adrenal insufficiency, also known as Addison's Disease, the neurological symptoms can begin in childhood or adulthood. The childhood cerebral form is the most severe, with onset between ages four and ten. 4)Common symptoms are behavioral changes, including abnormal withdrawal or aggression, poor memory, and poor school performance; and, additional symptoms include visual loss, learning disabilities, seizures, poorly articulated speech, difficulty swallowing, deafness, disturbances in gait and coordination, fatigue, intermittent vomiting, increased skin pigmentation, and progressive dementia. 5)Newborn screening is effective in catching and preventing the negative effects of X-ALD and is relatively inexpensive; and, treatment with adrenal hormones can be lifesaving, and symptomatic and supportive treatments for X-ALD include SCR 65 Page 2 physical therapy, psychological support, and special education. 6)Evidence suggests that a mixture of oleic acid and erucic acid, known as "Lorenzo's Oil," administered to boys with X-ALD prior to the onset of symptoms can prevent or delay, but not stop, the appearance of the childhood cerebral form of X-ALD. 7)The prognosis for patients with childhood cerebral X-ALD is generally poor due to progressive neurological deterioration, unless a bone marrow transplantation is performed early; and, death usually occurs between one and 10 years after the onset of symptoms. FISCAL EFFECT : None REGISTERED SUPPORT / OPPOSITION : Support None on file Opposition None on file Analysis Prepared by : Nicole Willis / RLS. / (916) 319-2800